A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma

This study has been terminated.

(Initial Principal Investigator left Moffitt)

Sponsor:

Collaborators:

Millennium Pharmaceuticals, Inc.

National Cancer Institute (NCI)

Information provided by:

H. Lee Moffitt Cancer Center and Research Institute

ClinicalTrials.gov Identifier:

NCT00361088

First received: August 3, 2006

Last updated: November 21, 2013

Last verified: May 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2007
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)